Quarterly report · Q2
7747.TEDINET S100Q7LY
Period2022-07-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥45.4bn | 2022-07-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥77.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥37.7bn | 2021-07-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥10.0bn | 2022-07-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥8.1bn | 2021-07-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥9.6bn | 2022-07-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥16.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.6bn | 2021-07-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥9.9bn | 2022-07-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥8.8bn | 2021-07-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.5bn | 2022-07-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥7.5bn | 2022-07-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥6.5bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥159.4bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥155.1bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥140.6bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥34.4bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥34.0bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥125.0bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥121.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥111.0bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥34.6bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥32.3bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥34.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.4bn | at 2021-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥8.7bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥17.3bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥9.7bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.9bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥18.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥11.2bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.6bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥11.4bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥12.7bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥27.52 | 2022-07-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.61 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.01 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.54 | 2021-07-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.23 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥40 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥23.53 | 2021-07-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 77.3% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.9% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-12-31 | −¥7.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-12-31 | −¥7.7bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-12-31 | −¥2.1bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥13.4bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥5.7bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥7.7bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥3.4bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥39.7bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥39.7bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2022-12-31 | ¥53.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2022-12-31 | ¥45.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2022-12-31 | ¥12.1bn |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2021-12-31 | −¥6.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2021-12-31 | −¥6.5bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-12-31 | −¥2.0bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥11.1bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥4.6bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue intersegment | 2021-07-01 → 2021-12-31 | ¥6.5bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥2.6bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥33.1bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥33.1bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥7.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2021-12-31 | ¥44.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2021-12-31 | ¥37.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-07-01 → 2021-12-31 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2021-12-31 | ¥10.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 487
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net inv cf | Prior1YTDDuration | 4000000 | JPY |
| Other net inv cf | CurrentYTDDuration | -1016000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -11182000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -4862000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | -1550000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 1995000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | 5262000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | － | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -312000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -245000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -2994000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -3256000000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | Prior1YTDDuration | 12383000000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYTDDuration | － | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -76000000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -71000000 | JPY |
| Other net fin cf | Prior1YTDDuration | -4000000 | JPY |
| Other net fin cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | 12708000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -1577000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 70000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 49000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 11323000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 2274000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 21358000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 32321000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 32682000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 34596000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -86000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -88000000 | JPY |
| Payrolls and bonuses sga | Prior1YTDDuration | 3524000000 | JPY |
| Payrolls and bonuses sga | CurrentYTDDuration | 4292000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 632000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 733000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 4295000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 4764000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02349-000MedicalReportableSegmentsMember | 33146000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02349-000DeviceReportableSegmentsMember | 4555000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 37702000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 37702000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02349-000MedicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02349-000DeviceReportableSegmentsMember | 6534000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 6534000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -6534000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02349-000MedicalReportableSegmentsMember | 33146000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02349-000DeviceReportableSegmentsMember | 11090000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 44236000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -6534000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |